Log in

NYSEAMERICAN:XXII22nd Century Group Stock Price, Forecast & News

$0.73
-0.01 (-1.55 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.72
Now: $0.73
$0.75
50-Day Range N/A
52-Week Range
$0.60
Now: $0.73
$2.46
Volume695,437 shs
Average Volume1.48 million shs
Market Capitalization$101.29 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine content cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. It is also involved in contract manufacturing business for third-party branded tobacco products. The company has a strategic research and development agreement with Keygene N.V. to develop hemp/cannabis plants for medical and therapeutic use, and other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
Read More
22nd Century Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.14 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Biotechnology
Sub-IndustryCannabis
SectorMedical
Current SymbolNYSEAMERICAN:XXII
CUSIPN/A
CIKN/A
Phone+1-716-2701523

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees82
Market Cap$101.29 million
Next Earnings Date11/5/2020 (Estimated)
OptionableOptionable
$0.73
-0.01 (-1.55 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive XXII News and Ratings via Email

Sign-up to receive the latest news and ratings for XXII and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











22nd Century Group (NYSEAMERICAN:XXII) Frequently Asked Questions

When is 22nd Century Group's next earnings date?

22nd Century Group is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for 22nd Century Group
.

How were 22nd Century Group's earnings last quarter?

22nd Century Group Inc (NYSEAMERICAN:XXII) released its quarterly earnings results on Thursday, August, 6th. The biotechnology company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $0.00.
View 22nd Century Group's earnings history
.

Has 22nd Century Group been receiving favorable news coverage?

Media headlines about XXII stock have been trending very positive recently, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. 22nd Century Group earned a media sentiment score of 4.0 on InfoTrie's scale. They also gave news stories about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days.
View the latest news about 22nd Century Group
.

Who are some of 22nd Century Group's key competitors?

What other stocks do shareholders of 22nd Century Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 22nd Century Group investors own include Cara Therapeutics (CARA), Canopy Growth (CGC), Novavax (NVAX), Cronos Group (CRON), Aurora Cannabis (ACB), KushCo (KSHB), Terra Tech (TRTC), Micron Technology (MU), Zynerba Pharmaceuticals (ZYNE) and Aurora Cannabis (ACBFF).

Who are 22nd Century Group's key executives?

22nd Century Group's management team includes the following people:
  • Mr. Henry Sicignano III, MBA, Pres, CEO & Director (Age 51)
  • Mr. John T. Brodfuehrer, CFO & Treasurer (Age 61)
  • Mr. Thomas L. James J.D., Esq., VP, Gen. Counsel & Sec. (Age 60)
  • James Vail, Director of Communications
  • Mr. James C. Morrison, Technical Advisor & Regulatory Affairs Consultant

What is 22nd Century Group's stock symbol?

22nd Century Group trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XXII."

Who are 22nd Century Group's major shareholders?

22nd Century Group's stock is owned by many different institutional and retail investors. Top institutional shareholders include Raymond James Financial Services Advisors Inc. (0.08%), Heritage Wealth Advisors (0.04%), UBS Group AG (0.04%) and Wealthcare Advisory Partners LLC (0.03%). Company insiders that own 22nd Century Group stock include Clifford B Fleet, Nora B Sullivan and Thomas L James.
View institutional ownership trends for 22nd Century Group
.

Which institutional investors are selling 22nd Century Group stock?

XXII stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, and Heritage Wealth Advisors.
View insider buying and selling activity for 22nd Century Group
.

Which institutional investors are buying 22nd Century Group stock?

XXII stock was purchased by a variety of institutional investors in the last quarter, including Wealthcare Advisory Partners LLC, and Raymond James Financial Services Advisors Inc.. Company insiders that have bought 22nd Century Group stock in the last two years include Clifford B Fleet, and Nora B Sullivan.
View insider buying and selling activity for 22nd Century Group
.

How do I buy shares of 22nd Century Group?

Shares of XXII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is 22nd Century Group's stock price today?

One share of XXII stock can currently be purchased for approximately $0.73.

How big of a company is 22nd Century Group?

22nd Century Group has a market capitalization of $101.29 million. 22nd Century Group employs 82 workers across the globe.

What is 22nd Century Group's official website?

The official website for 22nd Century Group is www.xxiicentury.com.

How can I contact 22nd Century Group?

22nd Century Group's mailing address is 9530 Main St, CLARENCE, NY 14031-1915, United States. The biotechnology company can be reached via phone at +1-716-2701523.

This page was last updated on 8/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.